GTH
Closed
Genetron Holdings Ltd
4.0201
-0.0049 (-0.12%)
Last Update: 29 Mar 2024 01:19:00
Yesterday: 4.025
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
1.04
Genetron Holdings Ltd. is a leading precision oncology company that specializes in developing and commercializing innovative molecular profiling solutions and AI-powered personalized cancer care solutions. The company was founded in 2015 and is headquartered in Beijing, China, with offices in the United States and Japan.
Genetron's core technology platform, HCCnext, is a proprietary sequencing-based cancer profiling system that provides comprehensive and accurate molecular information about a patient's cancer. This information is used to guide treatment decisions and improve patient outcomes. The company also offers a range of AI-powered cancer diagnostics and treatment solutions, including Genetron S5, a next-generation sequencing system, and Genetron Health Cloud, a cloud-based platform for storing and analyzing genomic data.
In addition to its technology platform, Genetron has established partnerships with leading hospitals and research institutions in China and around the world to advance cancer research and improve patient care. The company has also received numerous awards and recognitions for its innovative solutions and contributions to the field of precision oncology.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Genetron's core technology platform, HCCnext, is a proprietary sequencing-based cancer profiling system that provides comprehensive and accurate molecular information about a patient's cancer. This information is used to guide treatment decisions and improve patient outcomes. The company also offers a range of AI-powered cancer diagnostics and treatment solutions, including Genetron S5, a next-generation sequencing system, and Genetron Health Cloud, a cloud-based platform for storing and analyzing genomic data.
In addition to its technology platform, Genetron has established partnerships with leading hospitals and research institutions in China and around the world to advance cancer research and improve patient care. The company has also received numerous awards and recognitions for its innovative solutions and contributions to the field of precision oncology.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








